# BVI acquires ophthalmic viscoelastic device assets from Croma Pharma

BVI acquired the ophthalmic viscoelastic device (OVD) assets from Croma Pharma GmbH of Austria and launched NuVisc PRO in Europe. The companies also entered an R&D collaboration for additional products.

- Type: Acquisition
- Announced: 2020-05-15
- Where: Austria
- Status: completed
- Products: NuVisc PRO ophthalmic viscoelastic device, hyaluronic acid products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BVI](https://endata.com/companies/47280.md) (acquirer)
- [Croma Pharma GmbH](https://endata.com/companies/47281.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/bvi-expands-portfolio-with-new-viscoelastic-forges-strategic-partnership-with-croma-301060210.html), 2020-05-15: "BVI, the fastest growing diversified company in ophthalmology, today announced it has acquired the ophthalmic viscoelastic device (OVD) assets from Croma."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.